4//SEC Filing
Goldberg Itzhak 4
Accession 0001601485-21-000079
CIK 0001601485other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 6:03 PM ET
Size
8.2 KB
Accession
0001601485-21-000079
Insider Transaction Report
Form 4
Goldberg Itzhak
See Remarks
Transactions
- Sale
Common Stock
2021-12-03$3.39/sh−40,215$136,216→ 1,752,186 total - Sale
Common Stock
2021-12-01$3.54/sh−38,867$137,667→ 1,831,201 total - Sale
Common Stock
2021-12-02$3.51/sh−38,800$136,328→ 1,792,401 total
Footnotes (4)
- [F1]The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.31 to $3.79 inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.36 to $3.64 inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.29 to $3.50 inclusive.
Documents
Issuer
Angion Biomedica Corp.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001607858
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 6:03 PM ET
- Size
- 8.2 KB